Cancer burden in Mexico: urgent challenges to be met

Primary prevention of cancer was initiated with the introduction of Hepatitis B vaccine in the 80’s. However, in primary prevention of cancer at the worldwide level has been relatively recent. Intervention-action initiatives began at the global level in 2003 with the WHO Framework Convention on Toba...

Full description

Bibliographic Details
Main Authors: Eduardo Lazcano-Ponce, Alejandro Mohar-Betancourt, Abelardo Meneses-García, Mauricio Hernández-Ávila
Format: Article
Language:English
Published: Instituto Nacional de Salud Pública 2016-03-01
Series:Salud Pública de México
Subjects:
Online Access:http://www.saludpublica.mx/index.php/spm/article/view/7778
id doaj-ba4de3f2d81043aab3279cfed7521f79
record_format Article
spelling doaj-ba4de3f2d81043aab3279cfed7521f792020-11-25T01:10:25ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36341606-79162016-03-0158210110316137Cancer burden in Mexico: urgent challenges to be metEduardo Lazcano-PonceAlejandro Mohar-BetancourtAbelardo Meneses-GarcíaMauricio Hernández-ÁvilaPrimary prevention of cancer was initiated with the introduction of Hepatitis B vaccine in the 80’s. However, in primary prevention of cancer at the worldwide level has been relatively recent. Intervention-action initiatives began at the global level in 2003 with the WHO Framework Convention on Tobacco Control, which was the first treaty negotiated under WHO guidance and as of today includes 168 countries. This negotiation, although innovative, was somewhat overdue, considering that the causal association between exposure to tobacco and elevated cancer incidence was established over 65 years ago. Vaccines against hepatitis and more recently human papilloma virus are other noteworthy developments in primary cancer prevention. As for secondary prevention, it has focused on early detection of cancer, especially among women, first with screening based on the Pap test and later other strategies for cervical cancer detection. For breast cancer, early detection strategies such as mammograms and clinical breast examination have been used for many years. However, today their impact on mortality for this cancer has come into question. In this context, in Mexico we face enormous challenges to provide an efficient organized social response to cancer prevention and control. This issue of Salud Pública de México on “Cancer burden in Mexico: urgent challenges to be met” is an effort to estimate in epidemiological terms the breadth and depth of the problem faced in Latin America and particularly in Mexico. The authors do this by describing the enormous population-level and clinical challenges which need to be faced in the short term.   DOI: http://dx.doi.org/10.21149/spm.v58i2.7778http://www.saludpublica.mx/index.php/spm/article/view/7778cancerMexico
collection DOAJ
language English
format Article
sources DOAJ
author Eduardo Lazcano-Ponce
Alejandro Mohar-Betancourt
Abelardo Meneses-García
Mauricio Hernández-Ávila
spellingShingle Eduardo Lazcano-Ponce
Alejandro Mohar-Betancourt
Abelardo Meneses-García
Mauricio Hernández-Ávila
Cancer burden in Mexico: urgent challenges to be met
Salud Pública de México
cancer
Mexico
author_facet Eduardo Lazcano-Ponce
Alejandro Mohar-Betancourt
Abelardo Meneses-García
Mauricio Hernández-Ávila
author_sort Eduardo Lazcano-Ponce
title Cancer burden in Mexico: urgent challenges to be met
title_short Cancer burden in Mexico: urgent challenges to be met
title_full Cancer burden in Mexico: urgent challenges to be met
title_fullStr Cancer burden in Mexico: urgent challenges to be met
title_full_unstemmed Cancer burden in Mexico: urgent challenges to be met
title_sort cancer burden in mexico: urgent challenges to be met
publisher Instituto Nacional de Salud Pública
series Salud Pública de México
issn 0036-3634
1606-7916
publishDate 2016-03-01
description Primary prevention of cancer was initiated with the introduction of Hepatitis B vaccine in the 80’s. However, in primary prevention of cancer at the worldwide level has been relatively recent. Intervention-action initiatives began at the global level in 2003 with the WHO Framework Convention on Tobacco Control, which was the first treaty negotiated under WHO guidance and as of today includes 168 countries. This negotiation, although innovative, was somewhat overdue, considering that the causal association between exposure to tobacco and elevated cancer incidence was established over 65 years ago. Vaccines against hepatitis and more recently human papilloma virus are other noteworthy developments in primary cancer prevention. As for secondary prevention, it has focused on early detection of cancer, especially among women, first with screening based on the Pap test and later other strategies for cervical cancer detection. For breast cancer, early detection strategies such as mammograms and clinical breast examination have been used for many years. However, today their impact on mortality for this cancer has come into question. In this context, in Mexico we face enormous challenges to provide an efficient organized social response to cancer prevention and control. This issue of Salud Pública de México on “Cancer burden in Mexico: urgent challenges to be met” is an effort to estimate in epidemiological terms the breadth and depth of the problem faced in Latin America and particularly in Mexico. The authors do this by describing the enormous population-level and clinical challenges which need to be faced in the short term.   DOI: http://dx.doi.org/10.21149/spm.v58i2.7778
topic cancer
Mexico
url http://www.saludpublica.mx/index.php/spm/article/view/7778
work_keys_str_mv AT eduardolazcanoponce cancerburdeninmexicourgentchallengestobemet
AT alejandromoharbetancourt cancerburdeninmexicourgentchallengestobemet
AT abelardomenesesgarcia cancerburdeninmexicourgentchallengestobemet
AT mauriciohernandezavila cancerburdeninmexicourgentchallengestobemet
_version_ 1725174875288502272